Blogs

  • All Posts
  • Events
  • Medications
  • Studies
Vonozein: Clinical Evidence and Advantages of PCAB Therapy in GERD and H. pylori Eradication

February 23, 2026

1. Introduction: The Evolution of Acid Suppression Therapy For decades, Proton Pump Inhibitors (PPIs) have represented the standard of care for acid-related gastrointestinal disorders. However, real-world clinical data highlights persistent therapeutic gaps: Persistent Symptoms: In survey data of patients on daily PPI regimens, approximately 54% reported persistent reflux symptoms. High Recurrence: Up to 80% of...

Load More

End of Content.

Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.

Contact Info
Phone: +963986000022
E-Mail: info@zein-pharma.com

© 2026 Zein Pharma. All rights reserved.